Amneal Pharmaceuticals (AMRX) SEC Filings & 10K Form

$6.82
+0.07 (+1.04%)
(As of 05/17/2024 ET)

Recent Amneal Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/16/2024
2:13 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:39 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:42 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:43 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:44 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:46 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:18 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:19 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:23 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:28 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:31 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:34 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:35 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:38 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
5:03 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEF 14A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/14/2024
4:04 PM
Amneal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:39 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:40 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:54 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:03 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:09 PM
Amneal Pharmaceuticals (Subject)
Mahesh Akram (Filed by)
Form SC 13G
01/03/2024
3:30 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
12/26/2023
6:06 PM
Amneal Pharmaceuticals (Filer)
Form CERT
12/26/2023
3:10 PM
Amneal Pharmaceuticals (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
12/12/2023
5:04 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
11/20/2023
5:07 AM
Amneal Pharmaceuticals (Filer)
Form 15-12G
11/14/2023
11:15 PM
Amneal Pharmaceuticals (Filer)
Form EFFECT
11/14/2023
11:15 PM
Amneal Pharmaceuticals (Filer)
Form EFFECT
11/08/2023
5:20 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:21 PM
Amneal Pharmaceuticals (Issuer)
Patel Dipan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:21 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Shocking $16T Elon Musk Crypto Leak (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.
11/08/2023
5:22 PM
Amneal Pharmaceuticals (Issuer)
Patel Tushar Bhikhubhai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:20 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:03 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
11/08/2023
4:05 PM
Amneal Pharmaceuticals (Subject)
Patel Dipan (Filed by)
Form SC 13D/A
11/08/2023
4:07 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
11/08/2023
4:12 PM
Amneal Pharmaceuticals (Filer)
Form POS AM
11/08/2023
4:13 PM
Amneal Pharmaceuticals (Filer)
Form POS AM
11/08/2023
4:13 PM
Amneal Pharmaceuticals (Filer)
Form S-8 POS
11/08/2023
4:14 PM
Amneal Pharmaceuticals (Filer)
Form S-8 POS
11/08/2023
4:15 PM
Amneal Pharmaceuticals (Filer)
Form S-8 POS
11/08/2023
8:36 AM
Amneal Pharmaceuticals (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
11/08/2023
6:40 AM
Amneal Pharmaceuticals (Filer)
Form 8-K12B
11/07/2023
5:21 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
3:16 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
5:51 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
2:30 PM
Amneal Pharmaceuticals (Subject)
BOYER ANDREW S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
11:24 AM
Amneal Pharmaceuticals (Subject)
BOYER ANDREW S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
7:32 AM
Amneal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/04/2023
5:22 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AMRX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners